The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity

BackgroundThe incidence of nontuberculous mycobacterial lung disease (NTM-LD) is increasing worldwide. Immune exhaustion has been reported in NTM-LD, but T-cell immunoglobulin and mucin domain-containing protein 3 (TIM3), a co-inhibitory receptor on T cells, has been scarcely studied.MethodsPatients...

Full description

Bibliographic Details
Main Authors: Ping-Huai Wang, Ming-Fang Wu, Chi-Yu Hsu, Sheng-Wei Pan, Chin-Chung Shu, Shih-Lung Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.738056/full
_version_ 1818930231195467776
author Ping-Huai Wang
Ming-Fang Wu
Ming-Fang Wu
Chi-Yu Hsu
Sheng-Wei Pan
Sheng-Wei Pan
Chin-Chung Shu
Chin-Chung Shu
Shih-Lung Cheng
Shih-Lung Cheng
author_facet Ping-Huai Wang
Ming-Fang Wu
Ming-Fang Wu
Chi-Yu Hsu
Sheng-Wei Pan
Sheng-Wei Pan
Chin-Chung Shu
Chin-Chung Shu
Shih-Lung Cheng
Shih-Lung Cheng
author_sort Ping-Huai Wang
collection DOAJ
description BackgroundThe incidence of nontuberculous mycobacterial lung disease (NTM-LD) is increasing worldwide. Immune exhaustion has been reported in NTM-LD, but T-cell immunoglobulin and mucin domain-containing protein 3 (TIM3), a co-inhibitory receptor on T cells, has been scarcely studied.MethodsPatients with NTM-LD and healthy controls were prospectively recruited from July 2014 to August 2019 at three tertiary referral centers in Taiwan. We examined TIM3 expression on the T cells from the participants using flow cytometry. TIM3 expression was analyzed for different disease statuses and after treatment. The apoptosis and cytokine profiles were analyzed according to the TIM3 expression.ResultsAmong enrolled subjects (47 patients and 46 controls), TIM3 on CD4+ cells (6.44% vs. 4.12%, p = 0.028) and CD8+ cells (18.47% vs. 9.13%, p = 0.003) were higher in NTM-LD patients than in the controls. The TIM3 level on CD4+ and CD8+ T cells was positively associated with T-cell apoptosis in the NTM-LD patients. In stimulating peripheral blood mononuclear cells using PMA plus ionomycin, a high TIM3 level on T cells correlated with low interleukin-2 and tumor necrosis factor-alpha (TNF-α) on CD4+ cells and interferon-gamma and TNF-α on CD8+ T cells. For clinical manifestation, low body mass index (BMI), positive sputum acid-fast smear, and high radiographic score correlated with high TIM3 expression on T cells. After NTM treatment, TIM3+ decreased significantly on CD4+ and CD8+ T cells.ConclusionsIn patients with NTM-LD, TIM3+ expression increased over CD4+ and CD8+ T cells and correlated with cell apoptosis and specific cytokine attenuation. Clinically, TIM3+ T cells increased in patients with low BMI, high disease extent, and high bacilli burden but decreased after treatment.
first_indexed 2024-12-20T03:57:24Z
format Article
id doaj.art-e8e45c8f2dd1449597e6ac864c0a948b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T03:57:24Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e8e45c8f2dd1449597e6ac864c0a948b2022-12-21T19:54:16ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-11-011210.3389/fimmu.2021.738056738056The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical SeverityPing-Huai Wang0Ming-Fang Wu1Ming-Fang Wu2Chi-Yu Hsu3Sheng-Wei Pan4Sheng-Wei Pan5Chin-Chung Shu6Chin-Chung Shu7Shih-Lung Cheng8Shih-Lung Cheng9Division of Pulmonology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, TaiwanGraduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, TaiwanInstitute of Statistical Sciences, Academia Sinica, Taipei, TaiwanCollege of Medicine, National Taiwan University, Taipei, TaiwanDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCollege of Medicine, National Taiwan University, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanDivision of Pulmonology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, TaiwanDepartment of Chemical Engineering and Materials Science, Yuan Ze University, Taoyuan City, TaiwanBackgroundThe incidence of nontuberculous mycobacterial lung disease (NTM-LD) is increasing worldwide. Immune exhaustion has been reported in NTM-LD, but T-cell immunoglobulin and mucin domain-containing protein 3 (TIM3), a co-inhibitory receptor on T cells, has been scarcely studied.MethodsPatients with NTM-LD and healthy controls were prospectively recruited from July 2014 to August 2019 at three tertiary referral centers in Taiwan. We examined TIM3 expression on the T cells from the participants using flow cytometry. TIM3 expression was analyzed for different disease statuses and after treatment. The apoptosis and cytokine profiles were analyzed according to the TIM3 expression.ResultsAmong enrolled subjects (47 patients and 46 controls), TIM3 on CD4+ cells (6.44% vs. 4.12%, p = 0.028) and CD8+ cells (18.47% vs. 9.13%, p = 0.003) were higher in NTM-LD patients than in the controls. The TIM3 level on CD4+ and CD8+ T cells was positively associated with T-cell apoptosis in the NTM-LD patients. In stimulating peripheral blood mononuclear cells using PMA plus ionomycin, a high TIM3 level on T cells correlated with low interleukin-2 and tumor necrosis factor-alpha (TNF-α) on CD4+ cells and interferon-gamma and TNF-α on CD8+ T cells. For clinical manifestation, low body mass index (BMI), positive sputum acid-fast smear, and high radiographic score correlated with high TIM3 expression on T cells. After NTM treatment, TIM3+ decreased significantly on CD4+ and CD8+ T cells.ConclusionsIn patients with NTM-LD, TIM3+ expression increased over CD4+ and CD8+ T cells and correlated with cell apoptosis and specific cytokine attenuation. Clinically, TIM3+ T cells increased in patients with low BMI, high disease extent, and high bacilli burden but decreased after treatment.https://www.frontiersin.org/articles/10.3389/fimmu.2021.738056/fullapoptosiscytokineMycobacterium avium complexnontuberculous mycobacterialung diseaseT-cell immunoglobulin and mucin domain-containing protein 3 (TIM3)
spellingShingle Ping-Huai Wang
Ming-Fang Wu
Ming-Fang Wu
Chi-Yu Hsu
Sheng-Wei Pan
Sheng-Wei Pan
Chin-Chung Shu
Chin-Chung Shu
Shih-Lung Cheng
Shih-Lung Cheng
The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity
Frontiers in Immunology
apoptosis
cytokine
Mycobacterium avium complex
nontuberculous mycobacteria
lung disease
T-cell immunoglobulin and mucin domain-containing protein 3 (TIM3)
title The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity
title_full The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity
title_fullStr The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity
title_full_unstemmed The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity
title_short The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity
title_sort trend of tim3 expression on t cells in patients with nontuberculous mycobacterial lung disease from immune cell dysfunction to clinical severity
topic apoptosis
cytokine
Mycobacterium avium complex
nontuberculous mycobacteria
lung disease
T-cell immunoglobulin and mucin domain-containing protein 3 (TIM3)
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.738056/full
work_keys_str_mv AT pinghuaiwang thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT mingfangwu thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT mingfangwu thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT chiyuhsu thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT shengweipan thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT shengweipan thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT chinchungshu thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT chinchungshu thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT shihlungcheng thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT shihlungcheng thetrendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT pinghuaiwang trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT mingfangwu trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT mingfangwu trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT chiyuhsu trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT shengweipan trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT shengweipan trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT chinchungshu trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT chinchungshu trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT shihlungcheng trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity
AT shihlungcheng trendoftim3expressionontcellsinpatientswithnontuberculousmycobacteriallungdiseasefromimmunecelldysfunctiontoclinicalseverity